These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 35007660

  • 1. Peptide ligand interaction with maltose-binding protein tagged to the calcitonin gene-related peptide receptor: The inhibitory role of receptor N-glycosylation.
    Lee S.
    Peptides; 2022 Apr; 150():170735. PubMed ID: 35007660
    [Abstract] [Full Text] [Related]

  • 2. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA, Walker CS, Ly KN, Bailey RJ, Barwell J, Poyner DR, Hay DL.
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [Abstract] [Full Text] [Related]

  • 3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM, Booe JM, Lee SM, Warner ML, Pioszak AA.
    J Biol Chem; 2018 Oct 12; 293(41):15840-15854. PubMed ID: 30139742
    [Abstract] [Full Text] [Related]

  • 4. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE, Pioszak AA.
    Protein Sci; 2013 Dec 12; 22(12):1775-85. PubMed ID: 24115156
    [Abstract] [Full Text] [Related]

  • 5. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM, Warner ML, Roehrkasse AM, Hay DL, Pioszak AA.
    Mol Pharmacol; 2018 Apr 12; 93(4):355-367. PubMed ID: 29363552
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of components of the CGRP-receptor family in human coronary and human middle meningeal arteries: functional implications.
    de Vries T, Schutter D, van den Bogaerdt A, Vincent A, Dammers R, Danser AHJ, MaassenVanDenBrink A.
    J Headache Pain; 2024 Oct 10; 25(1):176. PubMed ID: 39390360
    [Abstract] [Full Text] [Related]

  • 7. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ, Reynolds CA, Simms J, Walker CS, Mobarec JC, Garelja ML, Conner AC, Poyner DR, Hay DL.
    Biochem Pharmacol; 2017 Oct 15; 142():96-110. PubMed ID: 28705698
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB, Wetzel-Strong SE, Dunn MK, Caron KM.
    Peptides; 2017 Feb 15; 88():1-7. PubMed ID: 27940069
    [Abstract] [Full Text] [Related]

  • 9. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.
    Booe JM, Walker CS, Barwell J, Kuteyi G, Simms J, Jamaluddin MA, Warner ML, Bill RM, Harris PW, Brimble MA, Poyner DR, Hay DL, Pioszak AA.
    Mol Cell; 2015 Jun 18; 58(6):1040-52. PubMed ID: 25982113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
    Lee SM, Hay DL, Pioszak AA.
    J Biol Chem; 2016 Apr 15; 291(16):8686-700. PubMed ID: 26895962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T, Ly K, Poyner DR, Christopoulos G, Sexton PM, Hay DL.
    Peptides; 2011 May 15; 32(5):1060-7. PubMed ID: 21402116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.
    Hill HE, Pioszak AA.
    Protein Expr Purif; 2013 Mar 15; 88(1):107-13. PubMed ID: 23247088
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ectodomain structures of the CGRP and AM receptors.
    Kusano S, Yokoyama S.
    Curr Protein Pept Sci; 2013 Aug 15; 14(5):375-85. PubMed ID: 23745701
    [Abstract] [Full Text] [Related]

  • 19. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein-coupled receptor.
    Babin KM, Karim JA, Gordon PH, Lennon J, Dickson A, Pioszak AA.
    J Biol Chem; 2023 Jun 15; 299(6):104785. PubMed ID: 37146967
    [Abstract] [Full Text] [Related]

  • 20. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
    Kunz TH, Scott M, Ittner LM, Fischer JA, Born W, Vogel J.
    Am J Physiol Heart Circ Physiol; 2007 Oct 15; 293(4):H2155-60. PubMed ID: 17660394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.